JPRN-UMIN000041683已完成未知
Clinical efficacy of nab-PTX+GEM chemotherapy plus zoledronate- activated autologous killer lymphocytes (ZAK cells) in patients with unresectable or recurrent pancreas cancer - PCaGNZAK
Kawasaki Medical School Department of Clinical Oncology0 个研究点目标入组 60 人开始时间: 2020年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Autoimmune disease 2) Uncontrollable complications including infection, diabetes, hypertension, ischemic heart disease, cerebral infarction, interstitial pneumonitis, cancer pain 3) Pregnancy 4) Allergy 5) General symptoms including dyspnea, jaundice, edema, effusions, clamp, paralysis, fracture, difficult for out-patient 6) Double cancer 7) Other cancer treatment 8) Steroid or immunosuppressive agents
研究者
相似试验
已完成
不适用
Clinical efficacy of nab-PTX+GEM chemotherapy plus zoledronate- activated autologous killer lymphocytes (ZAK cells) in patients with unresectable or recurrent pancreas cancerChemotherapy-naive unresectable or recurrent pancreatic cancerJPRN-UMIN000021827Kawasaki Medical School Department of Clinical Oncology60
已完成
1 期
Phase I/II trial of nab-PTX/CDGP for chemo-naive patients with advanced squamous cell lung cancer (KRSG-1302)Squamous cell lung cancerJPRN-UMIN000013219Kanto respiratory disease study group23
已完成
1 期
Phase I study of combination chemotherapy with nab-paclitaxel and Nedaplatin as first-line treatment in patients with advanced squamous cell lung cancer.Squamous cell lung cancerJPRN-UMIN000010963Kitasato University School of Medicine Department of Respiratory Medicine16
招募中
2 期
Phase II study of combination chemotherapy with TS-1/irinotecan and bevacizumab as second-line therapy in patient with K-RAS mutation-type metastatic colorectal canceradvanced/metastatic colorectal cancerJPRN-UMIN000005900PO FMPC (Future Medicine Promoting Consortium)40
招募中
1 期
Phase I/II trial of combined chemotherapy of Nab-paclitaxel, S-1, and Oxaliplatin for gastric cancer patients with peritoneal metastasis (NSOX study)gastric cancer with peritoneal metastasisJPRN-UMIN000030909Wakayama Medical University, School of Medicine35